News & Announcements
Showing 24 of 605 articles
-
-
Update from the Dean - Spring/Summer 2006
Seeking new funding sources for PhD programs. Thank you for alumni contributions. Meeting with PharmD alumni in industry. Faculty honors and awards: Ortiz de Montellano, Voigt, Wells, England, Hunt, Bero, Day. Global activity: McGee and Drysdale (Uganda), Nguyen (Ho Chi Minh City), Guglielmo, Gwaza, Monera, Benet, Wolfe, and UCSF ranked 9th among the top 100 global universities by Newsweek International. Li Foundation becomes partner in systems biology research (Peng, Tang). Helping seniors understand Medicare Part D (Stebbins, Cutler, Levens Lipton). Center for Consumer Self Care contributions: ClearRx Study, breast and prostate cancer screening, new residency program, telepharmacy service. Louie awarded Chancellor's Award for Public Service. Preparing for 2008 accreditation review. 40th Anniversary of clinical pharmacy. -
Update from the Dean - February 2006
Guglielmo named new department of clinical pharmacy chair. New faculty members: Boyd, Burchard, Cutler, Lee, MacDougall, Nkansah, Orrico, Tang, and Wells. Parfitt Pattie now oversees alumni relations in addition to fundraising. Research highlights. Honors and awards: Langridge, Giacomini, Herfindal, Gibson, Day, Nguyen, Zlott, Drysdale, and Allday. New PhD training program in systems biology. Postgraduate education of PharmD students. Employment trends of PharmD graduates. Homecoming scheduled for November 4, 2006. School at work in China, Vietnam, Japan, Uganda, and Guatemala. Lipton finishes sabbatical at One World Health. Victoria Hale to deliver commencement address to 2006 PharmD graduates. Strategic planning delayed by multiple factors. For 25th consecutive year, School tops other pharmacy schools in research funding from the National Institutes of Health. For second consecutive year, UCSF receives more federal funding for chemical research and development than any US peer. School exceeds campaign fundraising goal by 18%. -
Antivirals and the avian flu
The 2005 potential avian flu pandemic caused a shortage of antiviral drugs, leading to concerns about access, efficacy, and distribution.